Home/Filings/4/0001061983-21-000241
4//SEC Filing

SCHLOSSBERG MARK A 4

Accession 0001061983-21-000241

CIK 0001061983other

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 6:57 PM ET

Size

8.1 KB

Accession

0001061983-21-000241

Insider Transaction Report

Form 4
Period: 2021-10-19
SCHLOSSBERG MARK A
SVP - Legal & General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2021-10-19$7.03/sh+19,979$140,45270,829 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2021-10-1919,97915,265 total
    Exercise: $7.03From: 2020-01-31Exp: 2029-01-31Common Stock (19,979 underlying)
  • Sale

    Common Stock

    2021-10-19$35.74/sh19,979$713,97050,850 total
Footnotes (1)
  • [F1]Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 30, 2021.

Issuer

CYTOKINETICS INC

CIK 0001061983

Entity typeother

Related Parties

1
  • filerCIK 0001520533

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 6:57 PM ET
Size
8.1 KB